Showing results (51-60 of 90) with videos related to
Sort By:
Pageof 9
Alcohol and Alcoholism (Oxford, Oxfordshire)|April 29, 2000
United Kingdom Multicentre Acamprosate Study (UKMAS): a 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcoholJ Chick, H Howlett, M Y Morgan, et al.Scandinavian Journal of Gastroenterology|January 1, 1978
The detection of minimal alcoholic liver disease by three methodsJ Galizzi, M Y Morgan, A Chitranukroh, et al.Alimentary Pharmacology & Therapeutics|February 1, 1990
Pharmacokinetics of famotidine in normal subjects and in patients with chronic liver diseaseM Y Morgan, D Stambuk, J Cottrell, et al.Scandinavian Journal of Infectious Diseases|January 1, 1980
An epidemic of type B viral hepatitis: its course and outcomeA P Kirk, A Vitale, M Y Morgan, et al.Health Technology Assessment (Winchester, England)|February 16, 2012
Non-invasive diagnostic assessment tools for the detection of liver fibrosis in patients with suspected alcohol-related liver disease: a systematic review and economic evaluationM Stevenson, M Lloyd-Jones, M Y Morgan, et al.Hepatology (Baltimore, Md.)|September 1, 1983
Ethanol elimination in males and females: relationship to menstrual cycle and body compositionA W Marshall, D Kingstone, M Boss, et al.British Medical Journal|June 3, 1972
Successful use of oral diazoxide in the treatment of severe toxaemia of pregnancyJ E Pohl, H Thurston, D Davis, et al.The New Zealand Medical Journal|September 29, 2000
A decade of intensive care unit trauma admissions in AucklandJ P Gardiner, J A Judson, G S Smith, et al.Journal of the American Geriatrics Society|July 15, 1999
Psychotropic medication withdrawal and a home-based exercise program to prevent falls: a randomized, controlled trialA J Campbell, M C Robertson, M M Gardner, et al.Gastroenterology|April 1, 1980
Successful use of bromocriptine in the treatment of chronic hepatic encephalopathyM Y Morgan, A W Jakobovits, I M James, et al.Pageof 9